Industry Reports
Teva to Report Third Quarter 2010 Financial Results on November 2, 2010
Teva Pharmaceutical Industries Ltd. announced that it will release its third quarter 2010 financial results on Tuesday, November 2, 2010. Teva...
Drug Research
B. Braun Cefepime Now Available in Duplex drug delivery system
B. Braun, In an effort to meet industry demands for expanded Cephalosporin offerings delivered to patients through safe and accurate administration, B. Braun Medical...
Production & Manufacturing
European vaccine development moves forward
The European Vaccine Initiative, a product development partnership supporting the development of vaccines against diseases of poverty, has brought together to Brussels manufacturers, biotech...
Clinical Trials
Boehringer Ingelheim announced approval for TWYNSTA®. TWYNSTA single pill combination that delivers powerful and consistent blood pressure reductions
Boehringer Ingelheim announced today that the European Commission confirmed the positive opinion of the European Medicines Agency (EMA) approving TWYNSTA®. TWYNSTA® is indicated for...
IT & Data Management
McKesson Releases New Reporting Solution for EnterpriseRx
McKesson Pharmacy Systems LLC (MPS), a software division of McKesson Corporation, announced the launch of EnterpriseRx™ Reports Director at the 2010 National Association of...
IT & Data Management
CRM Software Provider Partners With Eastern European Pharma Services Company
StayinFront, Inc., a leading global provider of enterprise-wide customer relationship management (CRM) software, mobile sales force effectiveness and on-demand CRM solutions, announced today the...
Research Insight
Novartis Phase III study of Afinitor® plus Sandostatin® LAR® in patients with advanced neuroendocrine tumors showing potential benefit
A Novartis Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR® (octreotide acetate for injectable suspension) extended median progression-free survival (PFS),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read